Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...